LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -14.36%170.5M | 421.71%188.2M | 141.04%125.1M | -15.83%516.2M | 10.67%323.7M | 84.52%199.1M | -135.56%-58.5M | 7.23%51.9M | -13.58%613.3M | -11.95%292.5M |
Net income from continuing operations | 62.01%91.7M | -0.81%98.3M | 32.47%82M | -30.51%341.6M | 31.50%124M | -57.82%56.6M | -12.99%99.1M | -58.51%61.9M | -3.00%491.6M | -47.87%94.3M |
Operating gains losses | -105.28%-3M | 221.15%6.3M | -76.27%1.4M | 525.71%65.7M | 1,950.00%8.2M | 2,940.00%56.8M | -147.27%-5.2M | 436.36%5.9M | 125.80%10.5M | 100.74%400K |
Depreciation and amortization | 4.01%62.3M | 2.72%60.5M | 6.80%59.7M | 26.44%233.4M | 25.43%58.7M | 27.72%59.9M | 29.17%58.9M | 23.40%55.9M | -0.97%184.6M | -7.33%46.8M |
Deferred tax | 36.69%-8.8M | 66.26%-8.3M | -157.14%-7.2M | 6.40%-27.8M | 147.04%13.5M | -761.90%-13.9M | -2,975.00%-24.6M | -21.74%-2.8M | -179.62%-29.7M | -187.77%-28.7M |
Other non cash items | 104.00%15.3M | -18.46%10.6M | -86.41%2.5M | 51.95%50.6M | 64.79%11.7M | -36.97%7.5M | 47.73%13M | 234.55%18.4M | 4.72%33.3M | 22.41%7.1M |
Change In working capital | -103.49%-600K | 103.58%7.5M | 74.42%-28.8M | -9.56%-201.7M | -34.37%103.1M | 116.49%17.2M | -341.77%-209.4M | 40.58%-112.6M | -169.15%-184.1M | 64.85%157.1M |
-Change in receivables | 102.06%400K | -293.24%-14.3M | -196.01%-28.9M | 2,723.08%73.4M | -19.03%55.3M | 10.19%-19.4M | -43.08%7.4M | 152.71%30.1M | 102.34%2.6M | 984.13%68.3M |
-Change in inventory | -94.97%4M | -311.90%-26.7M | -4.69%-33.5M | 176.19%136M | -31.40%75.8M | 221.90%79.6M | 112.14%12.6M | 73.31%-32M | -7.72%-178.5M | 3,464.52%110.5M |
-Change in payables and accrued expense | -10.05%-40.5M | 188.52%29.3M | 175.96%47.7M | -70.32%-122.8M | 112.87%9.9M | 20.52%-36.8M | -181.53%-33.1M | -698.10%-62.8M | -134.98%-72.1M | -336.62%-76.9M |
-Change in other working capital | 672.58%35.5M | 109.78%19.2M | 70.56%-14.1M | -551.17%-288.3M | -168.66%-37.9M | -121.45%-6.2M | -7,110.71%-196.3M | -108.26%-47.9M | 2,942.86%63.9M | 3.37%55.2M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -14.36%170.5M | 421.71%188.2M | 141.04%125.1M | -15.83%516.2M | 10.67%323.7M | 84.52%199.1M | -135.56%-58.5M | 7.23%51.9M | -13.58%613.3M | -11.95%292.5M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -25.56%-67.3M | 8.55%-59.9M | 96.85%-38M | -467.16%-1.38B | 11.82%-52.2M | 12.99%-53.6M | -23.82%-65.5M | -1,641.56%-1.21B | -93.32%-243M | -306.99%-59.2M |
Capital expenditure reported | 9.79%-55.3M | 0.17%-58.7M | 27.43%-47.1M | -2.91%-244.2M | -10.04%-59.2M | 5.11%-61.3M | -13.29%-58.8M | 3.13%-64.9M | -11.36%-237.3M | 7.72%-53.8M |
Net business purchase and sale | -69.23%400K | 100.67%100K | 100.38%4.4M | -575,150.00%-1.15B | 3,400.00%10.5M | -38.10%1.3M | -2,383.33%-14.9M | -57,270.00%-1.15B | -100.22%-200K | -99.66%300K |
Net investment purchase and sale | -293.75%-12.4M | -104.08%-200K | -12.96%4.7M | 168.63%13.7M | -230.43%-3M | 392.31%6.4M | 880.00%4.9M | 440.00%5.4M | -39.29%5.1M | 283.33%2.3M |
Net other investing changes | --0 | ---- | ---- | 126.42%2.8M | 93.75%-500K | --0 | ---- | ---- | -2.91%-10.6M | -300.00%-8M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -25.56%-67.3M | 8.55%-59.9M | 96.85%-38M | -467.16%-1.38B | 11.82%-52.2M | 12.99%-53.6M | -23.82%-65.5M | -1,641.56%-1.21B | -93.32%-243M | -306.99%-59.2M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 3.96%-126M | -181.47%-86.6M | -106.92%-69.1M | 269.17%755.7M | -688.81%-218.5M | -112.64%-131.2M | 211.66%106.3M | 481.19%999.1M | 22.42%-446.7M | 85.91%-27.7M |
Net issuance payments of debt | 6.76%-95.1M | -137.08%-50.5M | -102.69%-30.8M | 16,190.32%997.6M | -10,144.44%-180.8M | -12,650.00%-102M | 2,719.23%136.2M | 57,310.00%1.14B | 75.49%-6.2M | 102.01%1.8M |
Net common stock issuance | --0 | --0 | --0 | 71.48%-79.9M | --0 | --0 | --0 | 60.07%-79.9M | 30.49%-280.2M | --0 |
Cash dividends paid | -1.04%-29.2M | -0.69%-29.1M | 1.93%-30.5M | 0.51%-117.9M | 0.00%-29M | 1.03%-28.9M | 1.03%-28.9M | 0.00%-31.1M | -2.51%-118.5M | 2.03%-29M |
Net other financing activities | -466.67%-1.7M | -600.00%-7M | 77.13%-7.8M | -5.50%-44.1M | -1,640.00%-8.7M | 82.35%-300K | 90.65%-1M | -17.99%-34.1M | -31.45%-41.8M | 86.49%-500K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 3.96%-126M | -181.47%-86.6M | -106.92%-69.1M | 269.17%755.7M | -688.81%-218.5M | -112.64%-131.2M | 211.66%106.3M | 481.19%999.1M | 22.42%-446.7M | 85.91%-27.7M |
Net cash flow | ||||||||||
Beginning cash position | 36.30%388.6M | 16.40%352.8M | -24.12%346.1M | -18.70%456.1M | 13.06%281.3M | 1.39%285.1M | 8.95%303.1M | -18.70%456.1M | 2.24%561M | -36.88%248.8M |
Current changes in cash | -259.44%-22.8M | 335.59%41.7M | 111.55%18M | -39.14%-106.3M | -74.22%53M | 192.86%14.3M | -207.93%-17.7M | 44.91%-155.9M | -1,031.71%-76.4M | 25.21%205.6M |
Effect of exchange rate changes | 211.60%20.2M | -1,866.67%-5.9M | -489.66%-11.3M | 87.02%-3.7M | 594.12%11.8M | -6.47%-18.1M | 97.76%-300K | 1,350.00%2.9M | -795.12%-28.5M | -34.62%1.7M |
End cash Position | 37.22%386M | 36.30%388.6M | 16.40%352.8M | -24.12%346.1M | -24.12%346.1M | 13.06%281.3M | 1.39%285.1M | 8.95%303.1M | -18.70%456.1M | -18.70%456.1M |
Free cash flow | -16.40%115.2M | 210.40%129.5M | 700.00%78M | -27.66%272M | 10.81%264.5M | 218.24%137.8M | -204.17%-117.3M | 30.11%-13M | -24.29%376M | -12.85%238.7M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |